Showing results (11-20 of 41) with videos related to
Sort By:
Pageof 5
Theranostics|June 1, 2019
High OGT activity is essential for MYC-driven proliferation of prostate cancer cellsHarri M Itkonen, Alfonso Urbanucci, Sara Es Martin, et al.Molecular Oncology|September 8, 2024
Patient-derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathwaysKatharina Bischof, Andrea Cremaschi, Lena Eroukhmanoff, et al.The Prostate|February 3, 2026
Happening in the Prostate Tumor Microenvironment: Ion Channels and Extrachromosomal DNA Driving Phenotypic PlasticitySara Darbandi, Alfonso Urbanucci, Sini Hakkola, et al.Methods in Molecular Biology (Clifton, N.J.)|January 1, 2022
Measuring Autophagic Cargo Flux with Keima-Based ProbesNikolai Engedal, Tonje Sønstevold, Carsten J Beese, et al.The Prostate|June 8, 2012
Goserelin and bicalutamide treatments alter the expression of microRNAs in the prostateSaara Lehmusvaara, Timo Erkkilä, Alfonso Urbanucci, et al.Scientific Reports|December 23, 2017
The expression of AURKA is androgen regulated in castration-resistant prostate cancerKati Kivinummi, Alfonso Urbanucci, Katri Leinonen, et al.Journal of Personalized Medicine|April 30, 2021
The Quandary of DNA-Based Treatment Assessment in De Novo Metastatic Prostate Cancer in the Era of Precision OncologySigve Nakken, Wolfgang Lilleby, Marta D Switlyk, et al.Oncogene|June 20, 2020
AR and ERG drive the expression of prostate cancer specific long noncoding RNAsAnnika Kohvakka, Mina Sattari, Anastasia Shcherban, et al.The Prostate|October 15, 2010
Androgen regulation of micro-RNAs in prostate cancerKati K Waltering, Kati P Porkka, Sanni E Jalava, et al.Cancers|July 2, 2020
Dysregulation of MITF Leads to Transformation in MC1R-Defective MelanocytesTimothy J Lavelle, Tine Norman Alver, Karen-Marie Heintz, et al.Pageof 5